188 related articles for article (PubMed ID: 12835119)
1. Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats.
Johnson-Davis KL; Hanson GR; Keefe KA
Neurotox Res; 2003; 5(4):273-81. PubMed ID: 12835119
[TBL] [Abstract][Full Text] [Related]
2. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
Shukla VK; Turndorf H; Bansinath M
Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593.
El Daly E; Chefer V; Sandill S; Shippenberg TS
J Neurochem; 2000 Apr; 74(4):1553-62. PubMed ID: 10737612
[TBL] [Abstract][Full Text] [Related]
4. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
[TBL] [Abstract][Full Text] [Related]
5. Effects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission.
Collins SL; D'Addario C; Izenwasser S
Eur J Pharmacol; 2001 Aug; 426(1-2):25-34. PubMed ID: 11525767
[TBL] [Abstract][Full Text] [Related]
6. Stimulatory effects of centrally injected kappa-opioid receptor agonists on gastric acid secretion in urethane-anesthetized rats.
Ishihara S; Tsuchiya S; Horie S; Murayama T; Watanabe K
Eur J Pharmacol; 2001 Apr; 418(3):187-94. PubMed ID: 11343688
[TBL] [Abstract][Full Text] [Related]
7. Role of serotonin in the regulation of the dynorphinergic system by a kappa-opioid agonist and cocaine treatment in rat CNS.
D'Addario C; Di Benedetto M; Izenwasser S; Candeletti S; Romualdi P
Neuroscience; 2007 Jan; 144(1):157-64. PubMed ID: 17055175
[TBL] [Abstract][Full Text] [Related]
8. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
9. Differential agonist regulation of the human kappa-opioid receptor.
Blake AD; Bot G; Li S; Freeman JC; Reisine T
J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509
[TBL] [Abstract][Full Text] [Related]
10. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
Shippenberg TS; LeFevour A; Heidbreder C
J Pharmacol Exp Ther; 1996 Feb; 276(2):545-54. PubMed ID: 8632320
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
12. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
[TBL] [Abstract][Full Text] [Related]
13. Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats.
McIntosh TK; Fernyak S; Yamakami I; Faden AI
Am J Physiol; 1994 Sep; 267(3 Pt 2):R665-72. PubMed ID: 7916537
[TBL] [Abstract][Full Text] [Related]
14. Activation of micro, delta or kappa opioid receptors by DAMGO, DPDPE, U-50488 or U-69593 respectively causes antinociception in the formalin test in the naked mole-rat (Heterocephalus glaber).
Towett PK; Kanui TI; Maloiy GM; Juma F; Olongida Ole Miaron J
Pharmacol Biochem Behav; 2009 Feb; 91(4):566-72. PubMed ID: 18929596
[TBL] [Abstract][Full Text] [Related]
15. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
Powell KR; Holtzman SG
Eur J Pharmacol; 1999 Jul; 377(1):21-8. PubMed ID: 10448921
[TBL] [Abstract][Full Text] [Related]
16. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
Smith MA; French AM
Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
[TBL] [Abstract][Full Text] [Related]
17. Depletion of serotonin decreases the effects of the kappa-opioid receptor agonist U-69593 on cocaine-stimulated activity.
Zakharova E; Collins SL; Aberg M; Kumar A; Fernandez JB; Izenwasser S
Eur J Pharmacol; 2008 May; 586(1-3):123-9. PubMed ID: 18395712
[TBL] [Abstract][Full Text] [Related]
18. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
Gullapalli S; Ramarao P
Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
[TBL] [Abstract][Full Text] [Related]
19. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
[TBL] [Abstract][Full Text] [Related]
20. Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists.
Heidbreder CA; Babovic-Vuksanovic D; Shoaib M; Shippenberg TS
J Pharmacol Exp Ther; 1995 Oct; 275(1):150-63. PubMed ID: 7562544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
